Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Author
Log in
Sign up
KL
Kelly Ling
Author with expertise in Acute Myeloid Leukemia
Achievements
This user has not unlocked any achievements yet.
Key Stats
Upvotes received:
0
Publications:
5
(0% Open Access)
Cited by:
0
h-index:
8
/
i10-index:
7
Reputation
Biology
< 1%
Chemistry
< 1%
Economics
< 1%
Show more
How is this calculated?
Overview
Publications
5
Peer Reviews
Comments
Grants
Publications
0
Outcomes with HMA Plus Venetoclax Vs Intensive Chemotherapy in AML Patients with Chromosome 5 and 7 Abnormalities
Leora Boussi
et al.
Nov 5, 2024
Oncology
Molecular Biology
0
Paper
Oncology
Molecular Biology
0
Save
0
Redefining Clinical Response Criteria in Myelodysplastic Syndromes to Better Forecast Post-Transplant Outcomes
Luis Aguirre
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
Comparative Analysis of Outcomes with HMA Plus Venetoclax Vs Intensive Chemotherapy in AML Patients Harboring Very-High Risk Cytogenetics
Luis Aguirre
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
The Prognostic and Predictive Value of
RUNX1
Mutations in Newly Diagnosed Acute Myeloid Leukemia - an International Multicenter Cohort Study
Rebecca Bystrom
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save
0
Venetoclax-Based Therapy Versus Intensive Chemotherapy Followed By Allogeneic-Stem Cell Transplantation for High-Risk Elderly Acute Myeloid Leukemia
Alexandre Iat
et al.
Nov 5, 2024
Genetics
Oncology
0
Paper
Genetics
Oncology
0
Save